ELUTIA INC (ELUT) Stock Price & Overview
NASDAQ:ELUT • US05479K1060
Current stock price
The current stock price of ELUT is 1.1 USD. Today ELUT is up by 4.76%. In the past month the price increased by 1.85%. In the past year, price decreased by -62.33%.
ELUT Key Statistics
- Market Cap
- 47.058M
- P/E
- 1.04
- Fwd P/E
- N/A
- EPS (TTM)
- 1.06
- Dividend Yield
- N/A
ELUT Stock Performance
ELUT Stock Chart
ELUT Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to ELUT. When comparing the yearly performance of all stocks, ELUT is one of the better performing stocks in the market, outperforming 78.43% of all stocks.
ELUT Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ELUT. Both the profitability and financial health of ELUT have multiple concerns.
ELUT Earnings
On March 11, 2026 ELUT reported an EPS of 1.48 and a revenue of 3.27M. The company beat EPS expectations (1136.41% surprise) and missed revenue expectations (-2.82% surprise).
ELUT Forecast & Estimates
8 analysts have analysed ELUT and the average price target is 3.57 USD. This implies a price increase of 224.55% is expected in the next year compared to the current price of 1.1.
For the next year, analysts expect an EPS growth of -148.59% and a revenue growth -36.51% for ELUT
ELUT Groups
Sector & Classification
ELUT Financial Highlights
Over the last trailing twelve months ELUT reported a non-GAAP Earnings per Share(EPS) of 1.06. The EPS increased by 142.91% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -90.02% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ELUT Ownership
ELUT Latest News, Press Relases and Analysis
ELUT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.82 | 364.65B | ||
| AMGN | AMGEN INC | 15.24 | 188.631B | ||
| GILD | GILEAD SCIENCES INC | 15.52 | 175.177B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.42 | 116.358B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.68 | 77.963B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 41.84 | 41.258B | ||
| INSM | INSMED INC | N/A | 31.039B | ||
| NTRA | NATERA INC | N/A | 28.733B | ||
| BIIB | BIOGEN INC | 11.29 | 26.917B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.55 | 23.098B | ||
| MRNA | MODERNA INC | N/A | 20.683B | ||
| EXAS | EXACT SCIENCES CORP | 345.14 | 19.837B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.676B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ELUT
Company Profile
Elutia, Inc. is a biotechnology company, which engages in the provision of biologic products to improve compatibility between medical devices and the patients who need them. The company is headquartered in Silver Spring, Maryland and currently employs 51 full-time employees. The company went IPO on 2020-10-08. Its portfolio of products spans the Women’s Health and Cardiovascular markets. In Women’s Health, it offers SimpliDerm, a novel biological matrix that leverages the inherent science of natural healing processes. SimpliDerm's design uses human-based hydrated acellular dermal matrix (ADM), which mitigates inflammation and enhances tissue incorporation. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. In addition, its TYKE product is designed for use in the neonatal patient population. The company is focused on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections following mastectomy. NXT-41x combines biologics and extended antibiotic release to provide protection while supporting tissue regeneration.
Company Info
IPO: 2020-10-08
ELUTIA INC
12510 Prosperity Drive, Suite 370
Silver Spring MARYLAND US
Employees: 51
Phone: 13026365400
ELUTIA INC / ELUT FAQ
Can you describe the business of ELUTIA INC?
Elutia, Inc. is a biotechnology company, which engages in the provision of biologic products to improve compatibility between medical devices and the patients who need them. The company is headquartered in Silver Spring, Maryland and currently employs 51 full-time employees. The company went IPO on 2020-10-08. Its portfolio of products spans the Women’s Health and Cardiovascular markets. In Women’s Health, it offers SimpliDerm, a novel biological matrix that leverages the inherent science of natural healing processes. SimpliDerm's design uses human-based hydrated acellular dermal matrix (ADM), which mitigates inflammation and enhances tissue incorporation. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. In addition, its TYKE product is designed for use in the neonatal patient population. The company is focused on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections following mastectomy. NXT-41x combines biologics and extended antibiotic release to provide protection while supporting tissue regeneration.
Can you provide the latest stock price for ELUTIA INC?
The current stock price of ELUT is 1.1 USD. The price increased by 4.76% in the last trading session.
What is the dividend status of ELUTIA INC?
ELUT does not pay a dividend.
What is the ChartMill technical and fundamental rating of ELUT stock?
ELUT has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the market cap for ELUTIA INC?
ELUTIA INC (ELUT) has a market capitalization of 47.06M USD. This makes ELUT a Nano Cap stock.
Who owns ELUTIA INC?
You can find the ownership structure of ELUTIA INC (ELUT) on the Ownership tab.
What is the Short Interest ratio of ELUTIA INC (ELUT) stock?
The outstanding short interest for ELUTIA INC (ELUT) is 0.46% of its float.